Cargando…

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics

Detalles Bibliográficos
Autor principal:	Liu, Linsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014239/ https://www.ncbi.nlm.nih.gov/pubmed/35444530 http://dx.doi.org/10.3389/fphar.2022.893905

Ejemplares similares

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Metabolomics as a tool in ethnobotany-driven drug discoveries
por: Makunga, Nokwanda, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disorders
por: Wu, Junbo, et al.
Publicado: (2022)

Editorial: Targeted drug discovery in ectopic calcification: mechanism, prospect, and clinical application
por: Xu, Kang, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology
por: Wang, Fu, et al.
Publicado: (2022)

Liquid Chromatograph-Mass Spectrometry-Based Non-targeted Metabolomics Discovery of Potential Endogenous Biomarkers Associated With Prostatitis Rats to Reveal the Effects of Magnoflorine
por: Yuan, Yin, et al.
Publicado: (2021)

Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine
por: Yuan, Yin, et al.
Publicado: (2022)

Editorial: New therapeutic targets for human placental angiogenesis disease
por: Escudero, Carlos A.
Publicado: (2014)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer
por: Ruan, Xujun, et al.
Publicado: (2022)

Editorial: Metabolomics and Ethnopharmacology in the Development of Herbal and Traditional Medicine
por: Ahmad, Sayeed, et al.
Publicado: (2022)

Therapeutic mechanisms of mulberry leaves in type 2 diabetes based on metabolomics
por: Ma, Quantao, et al.
Publicado: (2022)

An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers
por: Deng, Dawei, et al.
Publicado: (2021)

Metabolomics Reveals the Mechanisms for the Pulmonary Toxicity of Siegesbeckia orientalis L. and the Toxicity-Reducing Effect of Processing
por: Jiang, Ting, et al.
Publicado: (2021)

Editorial: Data mining and network-driven analysis: Drug discovery and mechanism exploration by targeting vascular dysfunction
por: Dai, Zhao, et al.
Publicado: (2022)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
por: Zhou, Fanfan, et al.
Publicado: (2022)

Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer
por: Yang, Yuting, et al.
Publicado: (2023)

Editorial: Treatment of Alzheimer’s disease-discovery of natural products based on neurite outgrowth and neuroprotection
por: Yang, Zhiyou, et al.
Publicado: (2022)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
por: Sun, Shouyuan, et al.
Publicado: (2022)

Rapid Discovery of the Potential Toxic Compounds in Polygonum multiflorum by UHPLC/Q-Orbitrap-MS-Based Metabolomics and Correlation Analysis
por: Han, Lifeng, et al.
Publicado: (2019)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
por: Polito, Letizia, et al.
Publicado: (2022)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
por: Nainu, Firzan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0ffvaco7c11psuojvqn4tlqt7